Antiallergic 9-oxo-11-hydroxy-5H,9H-[2]benzopyrano[4,3-g][1]benzopyrans

Area of Science:

• Pharmacology
• Immunology
• Medicinal Chemistry

Background:

• Anaphylaxis involves potent mediators that trigger allergic reactions.
• Passive cutaneous anaphylaxis (PCA) is a model for studying allergic responses.
• Slow-reacting substance of anaphylaxis (SRS-A) is a key mediator in anaphylaxis.

Purpose of the Study:

• To synthesize and characterize novel compounds.
• To evaluate the inhibitory effects of these compounds on PCA reactions.
• To assess the compounds' ability to block anaphylaxis mediators in smooth muscle.
• To develop an improved method for SRS-A isolation.

Main Methods:

• Chemical synthesis of novel compounds.
• In vivo passive cutaneous anaphylaxis assay in rats.
• In vitro smooth muscle contraction assays.
• Biochemical isolation and purification techniques for SRS-A.

Main Results:

• Several synthesized compounds demonstrated potent inhibition of PCA reactions.
• These compounds significantly blocked the effects of anaphylaxis mediators on isolated smooth muscle.
• An improved procedure for SRS-A isolation and partial purification was established.

Conclusions:

• The novel compounds are effective inhibitors of allergic reactions and mediators.
• The findings suggest potential therapeutic applications for these compounds in managing anaphylaxis.
• The improved SRS-A isolation method facilitates further research into anaphylaxis mechanisms.